The Cooper Companies, Inc. (NASDAQ:COO) Holdings Lifted by Arizona State Retirement System

Arizona State Retirement System grew its position in The Cooper Companies, Inc. (NASDAQ:COO) by 1.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 57,817 shares of the medical device company’s stock after purchasing an additional 769 shares during the period. Arizona State Retirement System’s holdings in Cooper Companies were worth $5,315,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Victory Capital Management Inc. boosted its holdings in shares of Cooper Companies by 23.0% in the third quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after acquiring an additional 737,726 shares in the last quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $691,000. Highland Capital Management LLC bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $4,004,000. Caprock Group LLC bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $282,000. Finally, Franklin Resources Inc. boosted its holdings in shares of Cooper Companies by 194.0% in the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after acquiring an additional 32,260 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 6.6 %

Shares of NASDAQ:COO opened at $85.00 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company has a market cap of $16.96 billion, a PE ratio of 43.59, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52 week low of $82.61 and a 52 week high of $112.38. The firm has a 50 day simple moving average of $92.38 and a 200 day simple moving average of $99.40.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

COO has been the subject of several recent research reports. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday. Piper Sandler reissued an “overweight” rating and set a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research note on Friday. Robert W. Baird cut their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating for the company in a research note on Friday. Citigroup cut their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday. Finally, StockNews.com lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, Cooper Companies currently has a consensus rating of “Moderate Buy” and a consensus target price of $111.89.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.